Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report.
Cancer stage
Colon cancer
Colonoscopy
Lynch syndrome
Surveillance
Survival
Journal
Hereditary cancer in clinical practice
ISSN: 1731-2302
Titre abrégé: Hered Cancer Clin Pract
Pays: Poland
ID NLM: 101231179
Informations de publication
Date de publication:
2019
2019
Historique:
received:
01
06
2019
accepted:
11
09
2019
entrez:
23
10
2019
pubmed:
23
10
2019
medline:
23
10
2019
Statut:
epublish
Résumé
We previously reported that in pathogenic mismatch repair ( The Prospective Lynch Syndrome Database (PLSD) that records outcomes of surveillance was examined to determine survival after colon cancer in relation to the time since previous colonoscopy and pathological stage. Only Ninety-nine In
Sections du résumé
BACKGROUND
BACKGROUND
We previously reported that in pathogenic mismatch repair (
METHODS
METHODS
The Prospective Lynch Syndrome Database (PLSD) that records outcomes of surveillance was examined to determine survival after colon cancer in relation to the time since previous colonoscopy and pathological stage. Only
RESULTS
RESULTS
Ninety-nine
CONCLUSIONS
CONCLUSIONS
In
Identifiants
pubmed: 31636762
doi: 10.1186/s13053-019-0127-3
pii: 127
pmc: PMC6792227
doi:
Types de publication
Journal Article
Langues
eng
Pagination
28Subventions
Organisme : Medical Research Council
ID : G0100496
Pays : United Kingdom
Organisme : Department of Health
ID : NIHR-CS-012-009
Pays : United Kingdom
Informations de copyright
© The Author(s). 2019.
Déclaration de conflit d'intérêts
Competing interestsToni Seppälä: a co-owner (20%) of Healthfund Finland Oy (educational and health care services in Finland, not related to patients or scope of this manuscript). Travel costs to a scientific meeting by Medtronic Finland. John Burn: a patent for high speed low cost tumor profiling pending to John Burn and QuantuMDx. All others: None declared.
Références
Hered Cancer Clin Pract. 2019 Feb 28;17:8
pubmed: 30858900
Eur J Surg Oncol. 2014 Dec;40(12):1789-96
pubmed: 25454831
Cancers (Basel). 2019 Jan 23;11(2):null
pubmed: 30678073
Gut. 2017 Mar;66(3):464-472
pubmed: 26657901
Gut. 2017 Sep;66(9):1657-1664
pubmed: 27261338
Gut. 2018 Jul;67(7):1306-1316
pubmed: 28754778
Genet Med. 2019 Jul 24;:null
pubmed: 31337882
Hered Cancer Clin Pract. 2017 Oct 10;15:18
pubmed: 29046738
Am J Gastroenterol. 2015 Feb;110(2):223-62; quiz 263
pubmed: 25645574
J Pathol. 2018 Oct;246(2):129-133
pubmed: 30027543
Gastroenterology. 2018 Nov;155(5):1400-1409.e2
pubmed: 30063918
Therap Adv Gastroenterol. 2018 May 27;11:1756284818775058
pubmed: 29872454
Int J Cancer. 2018 Jul 1;143(1):139-150
pubmed: 29424427